Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 90 points (0.6%) at 15,153 as of Tuesday, Sept. 10, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,842 issues advancing vs. 1,092 declining with 95 unchanged. The Materials & Construction industry currently sits up 0.6% versus the S&P 500, which is up 0.5%. Top gainers within the industry include Chicago Bridge & Iron Company ( CBI), up 3.3%, Quanta Services ( PWR), up 2.0%, Martin Marietta Materials ( MLM), up 1.6%, Vulcan Materials Company ( VMC), up 1.6% and Stericycle Incorporated ( SRCL), up 0.8%. TheStreet would like to highlight 4 stocks pushing the industry lower today: 4. DR Horton ( DHI) is one of the companies pushing the Materials & Construction industry lower today. As of noon trading, DR Horton is down $0.13 (-0.7%) to $19.15 on average volume. Thus far, 3.8 million shares of DR Horton exchanged hands as compared to its average daily volume of 8.0 million shares. The stock has ranged in price between $18.84-$19.37 after having opened the day at $19.11 as compared to the previous trading day's close of $19.28. D.R. Horton, Inc. operates as a homebuilding company. The company engages in the acquisition and development of land; and construction and sale of residential homes in 26 states and 77 markets in the United States primarily under the D.R. Horton, America's Builder name. DR Horton has a market cap of $5.8 billion and is part of the industrial goods sector. Shares are down 8.5% year to date as of the close of trading on Monday. Currently there are 9 analysts that rate DR Horton a buy, 2 analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates DR Horton as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and attractive valuation levels. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DR Horton Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.